| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 18 | 2013 | 434 | 1.290 |
Why?
|
| Receptors, Estrogen | 19 | 2010 | 723 | 1.190 |
Why?
|
| Selective Estrogen Receptor Modulators | 6 | 2014 | 51 | 0.760 |
Why?
|
| Tamoxifen | 9 | 2012 | 350 | 0.740 |
Why?
|
| Transcortin | 16 | 1994 | 17 | 0.710 |
Why?
|
| Estrogen Receptor beta | 5 | 2012 | 77 | 0.700 |
Why?
|
| Estradiol | 15 | 2012 | 481 | 0.600 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2012 | 180 | 0.580 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 530 | 0.560 |
Why?
|
| Transcription Factors | 13 | 2009 | 2437 | 0.540 |
Why?
|
| Estrogen Antagonists | 6 | 2012 | 92 | 0.520 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2012 | 16 | 0.450 |
Why?
|
| Trans-Activators | 8 | 2005 | 692 | 0.440 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2014 | 16 | 0.430 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2014 | 49 | 0.420 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 2 | 2012 | 32 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 1989 | 0.410 |
Why?
|
| Estrogens | 6 | 2009 | 436 | 0.400 |
Why?
|
| Indoles | 1 | 2014 | 205 | 0.390 |
Why?
|
| Breast | 1 | 2014 | 216 | 0.380 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 2648 | 0.330 |
Why?
|
| Transcription, Genetic | 9 | 2013 | 1397 | 0.310 |
Why?
|
| HeLa Cells | 14 | 2009 | 694 | 0.300 |
Why?
|
| RNA, Messenger | 13 | 2014 | 2568 | 0.300 |
Why?
|
| Urogenital Neoplasms | 1 | 2007 | 14 | 0.260 |
Why?
|
| Ligands | 12 | 2010 | 486 | 0.250 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 45 | 0.240 |
Why?
|
| Apoptosis | 1 | 2012 | 1861 | 0.230 |
Why?
|
| Histone Acetyltransferases | 10 | 2006 | 224 | 0.230 |
Why?
|
| Transcriptional Activation | 6 | 2009 | 414 | 0.230 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2463 | 0.220 |
Why?
|
| Receptors, Steroid | 6 | 2006 | 172 | 0.220 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 3673 | 0.220 |
Why?
|
| Hydrocortisone | 5 | 1994 | 224 | 0.200 |
Why?
|
| Down-Regulation | 3 | 2014 | 659 | 0.180 |
Why?
|
| Benzazepines | 1 | 2001 | 44 | 0.180 |
Why?
|
| Signal Transduction | 7 | 2014 | 4683 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 112 | 0.170 |
Why?
|
| Nuclear Receptor Coactivator 1 | 8 | 2006 | 162 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 7 | 2006 | 989 | 0.170 |
Why?
|
| Growth Substances | 2 | 1998 | 102 | 0.170 |
Why?
|
| Base Sequence | 15 | 2001 | 2783 | 0.160 |
Why?
|
| DNA | 11 | 2005 | 1442 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2009 | 1571 | 0.150 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 1226 | 0.150 |
Why?
|
| CREB-Binding Protein | 3 | 2006 | 55 | 0.140 |
Why?
|
| Anti-Allergic Agents | 1 | 1998 | 29 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 5 | 2009 | 723 | 0.140 |
Why?
|
| Humans | 45 | 2014 | 131680 | 0.140 |
Why?
|
| Protein Binding | 6 | 2006 | 1712 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1998 | 105 | 0.140 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2009 | 257 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1998 | 133 | 0.130 |
Why?
|
| Dopamine | 3 | 1996 | 256 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 1998 | 350 | 0.120 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 1994 | 50 | 0.120 |
Why?
|
| Molecular Sequence Data | 13 | 2000 | 3616 | 0.120 |
Why?
|
| Steroids | 1 | 1996 | 172 | 0.120 |
Why?
|
| Acetyltransferases | 2 | 2005 | 73 | 0.110 |
Why?
|
| Oncogene Proteins | 2 | 2005 | 135 | 0.110 |
Why?
|
| Liver | 8 | 1993 | 1799 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 1958 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2014 | 31 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 38 | 0.100 |
Why?
|
| Animals | 27 | 2009 | 34375 | 0.100 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2013 | 39 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2012 | 19 | 0.100 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 47 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 1997 | 777 | 0.090 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 136 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2012 | 127 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 64 | 0.090 |
Why?
|
| Histidine | 1 | 1992 | 74 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 109 | 0.090 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 57 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2014 | 322 | 0.090 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 209 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 344 | 0.090 |
Why?
|
| Thyroxine | 1 | 1992 | 62 | 0.090 |
Why?
|
| Receptors, Progesterone | 7 | 2006 | 680 | 0.090 |
Why?
|
| Bone Density | 1 | 2014 | 363 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 427 | 0.090 |
Why?
|
| Gene Expression Regulation | 5 | 2009 | 2357 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 598 | 0.090 |
Why?
|
| Leucine | 1 | 1992 | 262 | 0.090 |
Why?
|
| Hormones | 1 | 1992 | 165 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 387 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 482 | 0.090 |
Why?
|
| Rats | 9 | 2004 | 3460 | 0.090 |
Why?
|
| Genes | 3 | 1991 | 308 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 491 | 0.080 |
Why?
|
| Dexamethasone | 1 | 1992 | 261 | 0.080 |
Why?
|
| Binding Sites | 7 | 2010 | 1202 | 0.080 |
Why?
|
| Casein Kinase II | 1 | 2009 | 12 | 0.080 |
Why?
|
| Genes, Overlapping | 1 | 1989 | 7 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 1989 | 26 | 0.080 |
Why?
|
| Multienzyme Complexes | 2 | 2001 | 77 | 0.080 |
Why?
|
| Female | 18 | 2014 | 71186 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 489 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 113 | 0.080 |
Why?
|
| Casein Kinase Idelta | 1 | 2009 | 4 | 0.080 |
Why?
|
| Amino Acid Sequence | 11 | 2000 | 2564 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2005 | 567 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 1236 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2014 | 807 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2012 | 1521 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1322 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1626 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2010 | 358 | 0.070 |
Why?
|
| Testis | 1 | 1989 | 413 | 0.070 |
Why?
|
| Exons | 1 | 1989 | 769 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2014 | 894 | 0.060 |
Why?
|
| Activating Transcription Factors | 1 | 2006 | 3 | 0.060 |
Why?
|
| CHO Cells | 4 | 2001 | 149 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 261 | 0.060 |
Why?
|
| Nuclear Matrix | 3 | 2001 | 17 | 0.060 |
Why?
|
| Nandrolone | 1 | 2006 | 6 | 0.060 |
Why?
|
| Cricetinae | 4 | 2001 | 367 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1021 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 786 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1277 | 0.060 |
Why?
|
| Progestins | 2 | 2006 | 42 | 0.060 |
Why?
|
| Receptors, Dopamine | 2 | 1996 | 30 | 0.060 |
Why?
|
| DNA Primers | 3 | 2001 | 609 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 80 | 0.060 |
Why?
|
| Fetus | 4 | 1993 | 585 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2001 | 242 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 11 | 0.050 |
Why?
|
| Transfection | 6 | 2006 | 960 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 254 | 0.050 |
Why?
|
| Biological Transport | 3 | 2001 | 333 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 2001 | 114 | 0.050 |
Why?
|
| Middle Aged | 3 | 2014 | 28889 | 0.050 |
Why?
|
| Mutation | 6 | 2010 | 6177 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 61 | 0.050 |
Why?
|
| Myelin P0 Protein | 1 | 2004 | 28 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 286 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 1218 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 158 | 0.050 |
Why?
|
| Aging | 1 | 1991 | 1265 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2004 | 150 | 0.050 |
Why?
|
| Gravitation | 1 | 2002 | 11 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 665 | 0.050 |
Why?
|
| Ligases | 2 | 2000 | 35 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 1316 | 0.050 |
Why?
|
| Calcitriol | 1 | 2002 | 62 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2002 | 59 | 0.050 |
Why?
|
| Cell Line | 3 | 2009 | 2605 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2001 | 589 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 694 | 0.040 |
Why?
|
| Inositol Phosphates | 1 | 2001 | 12 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2001 | 350 | 0.040 |
Why?
|
| Lac Operon | 1 | 2001 | 89 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 159 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 189 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 677 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 864 | 0.040 |
Why?
|
| Norpregnenes | 2 | 2001 | 2 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 131 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 2 | 1996 | 60 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 39 | 0.040 |
Why?
|
| Posture | 2 | 1996 | 136 | 0.040 |
Why?
|
| Drug Design | 1 | 1999 | 166 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 68 | 0.040 |
Why?
|
| Response Elements | 1 | 1998 | 99 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 1992 | 1024 | 0.030 |
Why?
|
| Antibodies, Phospho-Specific | 2 | 2009 | 2 | 0.030 |
Why?
|
| Neutrophils | 2 | 1990 | 372 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 107 | 0.030 |
Why?
|
| Plasmids | 1 | 1998 | 455 | 0.030 |
Why?
|
| Kinetics | 5 | 2000 | 1101 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1996 | 33 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2010 | 810 | 0.030 |
Why?
|
| Leupeptins | 3 | 2001 | 21 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2001 | 34 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 1993 | 126 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1994 | 1489 | 0.030 |
Why?
|
| Glycosylation | 2 | 1992 | 122 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1994 | 16 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 901 | 0.030 |
Why?
|
| Desogestrel | 1 | 1994 | 7 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 260 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 199 | 0.030 |
Why?
|
| Half-Life | 2 | 1991 | 151 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 60 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 17 | 0.030 |
Why?
|
| Mice | 3 | 2007 | 18488 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 300 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 195 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 1992 | 18 | 0.020 |
Why?
|
| Catalysis | 1 | 2013 | 137 | 0.020 |
Why?
|
| Fetal Blood | 2 | 1991 | 179 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 255 | 0.020 |
Why?
|
| Rats, Inbred BB | 1 | 1991 | 5 | 0.020 |
Why?
|
| Deoxyribonucleotides | 1 | 1991 | 7 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 283 | 0.020 |
Why?
|
| Corticosterone | 1 | 1991 | 53 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 358 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2007 | 12984 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 450 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 61 | 0.020 |
Why?
|
| Models, Biological | 1 | 1995 | 1392 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 69 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 157 | 0.020 |
Why?
|
| Pregnancy | 6 | 1993 | 7572 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 312 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1087 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 249 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 803 | 0.020 |
Why?
|
| Progesterone | 2 | 2006 | 446 | 0.020 |
Why?
|
| Leukocytes | 1 | 1990 | 211 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 82 | 0.020 |
Why?
|
| Gene Library | 1 | 1989 | 213 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 620 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 410 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 2971 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1989 | 149 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 163 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1999 | 824 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 496 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1987 | 95 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2000 | 364 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 81 | 0.020 |
Why?
|
| Mifepristone | 1 | 2006 | 89 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 20 | 0.010 |
Why?
|
| Valine | 1 | 1985 | 110 | 0.010 |
Why?
|
| Rabbits | 3 | 1991 | 633 | 0.010 |
Why?
|
| Lysine | 1 | 1985 | 175 | 0.010 |
Why?
|
| Jejunum | 1 | 1985 | 124 | 0.010 |
Why?
|
| Molecular Weight | 3 | 1990 | 297 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2001 | 1018 | 0.010 |
Why?
|
| Sequence Alignment | 2 | 2000 | 595 | 0.010 |
Why?
|
| Biglycan | 1 | 2004 | 6 | 0.010 |
Why?
|
| Collagen Type III | 1 | 2004 | 23 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 79 | 0.010 |
Why?
|
| 20-alpha-Dihydroprogesterone | 1 | 2004 | 1 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 114 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 3239 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 452 | 0.010 |
Why?
|
| Lung | 2 | 1992 | 1565 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 179 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2004 | 62 | 0.010 |
Why?
|
| Male | 6 | 2004 | 65267 | 0.010 |
Why?
|
| Norethindrone | 1 | 2001 | 8 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2001 | 11 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 19 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 275 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2001 | 48 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1992 | 366 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 216 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1190 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 149 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 318 | 0.010 |
Why?
|
| Granulocytes | 2 | 1990 | 69 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 442 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6279 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 359 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 45 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 335 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 382 | 0.010 |
Why?
|
| Gene Expression | 2 | 1994 | 1502 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 566 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 286 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1999 | 79 | 0.010 |
Why?
|
| Placenta | 2 | 1993 | 529 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1999 | 92 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 258 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 773 | 0.010 |
Why?
|
| Aged | 2 | 1992 | 21261 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 26 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 1996 | 39 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 73 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 944 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1994 | 11 | 0.010 |
Why?
|
| Biological Availability | 1 | 1994 | 140 | 0.010 |
Why?
|
| Saimiri | 1 | 1994 | 11 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 1010 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 149 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 141 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1994 | 331 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1999 | 984 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 436 | 0.010 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1992 | 18 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 625 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 121 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1992 | 46 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 236 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 225 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1992 | 205 | 0.010 |
Why?
|
| Serpins | 1 | 1991 | 34 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 12 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1990 | 51 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1990 | 81 | 0.000 |
Why?
|
| Autoradiography | 1 | 1989 | 65 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 74 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 1610 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 4516 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1990 | 358 | 0.000 |
Why?
|
| Monocytes | 1 | 1990 | 337 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 71 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1987 | 108 | 0.000 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1987 | 88 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1987 | 199 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1990 | 781 | 0.000 |
Why?
|
| Gestational Age | 1 | 1990 | 1221 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1985 | 52 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1985 | 73 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1985 | 170 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 13306 | 0.000 |
Why?
|
| Inflammation | 1 | 1990 | 1492 | 0.000 |
Why?
|
| Adult | 2 | 1994 | 31719 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1985 | 765 | 0.000 |
Why?
|
| Age Factors | 1 | 1985 | 2872 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1990 | 6925 | 0.000 |
Why?
|